AITRICS is a Seoul-based medical AI company founded in 2017 that develops software to assist clinicians with real-time decision making and operational efficiency. Its flagship platforms, AITRICS-VC (VitalCare) and V.Doc Pro, analyze patient data to predict clinical deterioration and guide treatment. The firm has expanded internationally with subsidiaries in Japan and the United States. Fresh capital will be directed toward enhancing these core products, advancing new R&D pipelines, and growing sales operations across Asia and North America. Since inception the company has raised a cumulative ₩73.1 billion (≈ $55 million) in venture funding, including the newly announced Series C. No revenue or user figures were disclosed in the article, but management positions the offering as a critical tool for improving patient outcomes and hospital efficiency.

Total raised

$44M

Funding rounds

2

Latest round

Series C

Latest activity

Dec 2025